CBX3 and cancer: Specifically, the Kaplan–Meier curves of all the cancers (Fig. 3c) showed that high expression of CBX3 was significantly correlated with poor prognosis of patients in ACC, CESC, HNSC, KICH, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PRAD, and UVM.